108 related articles for article (PubMed ID: 12081739)
1. Retrospective study of acute toxicity following short-course preoperative radiotherapy.
Hartley A; Giridharan S; Gray L; Billingham L; Ismail T; Geh JI
Br J Surg; 2002 Jul; 89(7):889-95. PubMed ID: 12081739
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. Multicentre prospective audit of surgical outcomes and acute complications following short course pre-operative radiotherapy for resectable rectal cancer.
Giridharan S; Vakkalanka B; Anwar MS; Geh JI; Glaholm J; Churn M; Adab F; Grieve R; McConkey C; Hartley A
Colorectal Dis; 2005 Jan; 7(1):43-6. PubMed ID: 15606583
[TBL] [Abstract][Full Text] [Related]
4. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.
Arnaud JP; Nordlinger B; Bosset JF; Boes GH; Sahmoud T; Schlag PM; Pene F
Br J Surg; 1997 Mar; 84(3):352-7. PubMed ID: 9117306
[TBL] [Abstract][Full Text] [Related]
5. Short course preoperative radiotherapy is the single most important risk factor for perineal wound complications after abdominoperineal excision of the rectum.
Chadwick MA; Vieten D; Pettitt E; Dixon AR; Roe AM
Colorectal Dis; 2006 Nov; 8(9):756-61. PubMed ID: 17032320
[TBL] [Abstract][Full Text] [Related]
6. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer.
Pettersson D; Holm T; Iversen H; Blomqvist L; Glimelius B; Martling A
Br J Surg; 2012 Apr; 99(4):577-83. PubMed ID: 22241246
[TBL] [Abstract][Full Text] [Related]
7. Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer.
Brooks S; Glynne-Jones R; Novell R; Harrison M; Brown K; Makris A
Acta Oncol; 2006; 45(8):1079-85. PubMed ID: 17118843
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
[TBL] [Abstract][Full Text] [Related]
9. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
10. Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer.
Fokstuen T; Holm T; Glimelius B
Radiother Oncol; 2009 Nov; 93(2):293-7. PubMed ID: 19748694
[TBL] [Abstract][Full Text] [Related]
11. A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.
Penopoulos V; Handolias M; Avgerinos A; Maris T; Ilias T; Issopoulos N; Christianopoulos G; Betsis D; Vrettou E; Kitis G; Pistevou K
Hepatogastroenterology; 2008; 55(85):1280-7. PubMed ID: 18795673
[TBL] [Abstract][Full Text] [Related]
12. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
13. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy.
Holm T; Johansson H; Cedermark B; Ekelund G; Rutqvist LE
Br J Surg; 1997 May; 84(5):657-63. PubMed ID: 9171755
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
15. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
16. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
[TBL] [Abstract][Full Text] [Related]
18. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
[TBL] [Abstract][Full Text] [Related]
19. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
20. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
